Anavex Life Sciences is navigating leadership changes while aligning on the Phase 3 protocol for adult Rett syndrome with the FDA.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Anavex Life Sciences is navigating leadership changes while aligning on the Phase 3 protocol for adult Rett syndrome with the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Anavex Life Sciences submitted data for FDA discussions and received scientific advice from the EMA.Sub-event
Anavex Life Sciences faces leadership challenges while working on Phase 3 Rett syndrome trials with FDA oversight.1 source